StockData
MariMed Inc. logo

MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

MariMed's operating cash flow for the twelve months ending Sep 30, 2026 was $10.08M, up 161.7% year over year. For fiscal 2025 it was $7.70M, up 13.4% from the year before. The highest annual figure on record is $35.86M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.70M+13.4%
FY2024Dec 31, 2024$6.79M-14.2%
FY2023Dec 31, 2023$7.91M+8.2%
FY2022Dec 31, 2022$7.31M-79.6%
FY2021Dec 31, 2021$35.86M+960.7%
FY2020Dec 31, 2020$3.38M–
FY2019Dec 31, 2019-$24.14M–
FY2018Dec 31, 2018-$2.91M-264.8%
FY2017Dec 31, 2017$1.76M–
FY2016Dec 31, 2016-$197.93K–
FY2015Dec 31, 2015-$392.88K–
FY2014Dec 31, 2014-$455.22K–
FY2013Dec 31, 2013-$10.65K–
FY2012Dec 31, 2012-$127.47K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.49M+30.3%
Q2 FY2026Jun 30, 2026$2.22M+647.1%
Q1 FY2026Mar 31, 2026$949.00K-26.6%
Q4 FY2025Dec 31, 2025$3.43M–
Q3 FY2025Sep 30, 2025$2.68M+233.3%
Q2 FY2025Jun 30, 2025$297.00K-90.7%
Q1 FY2025Mar 31, 2025$1.29M-59.7%
Q4 FY2024Dec 31, 2024-$413.00K-112.8%
Q3 FY2024Sep 30, 2024$803.00K-89.8%
Q2 FY2024Jun 30, 2024$3.19M+149.8%
Q1 FY2024Mar 31, 2024$3.21M–
Q4 FY2023Dec 31, 2023$3.23M+86.2%
Q3 FY2023Sep 30, 2023$7.90M+136.2%
Q2 FY2023Jun 30, 2023$1.28M–
Q1 FY2023Mar 31, 2023-$4.50M-153.0%
Q4 FY2022Dec 31, 2022$1.74M-77.2%
Q3 FY2022Sep 30, 2022$3.35M-50.5%
Q2 FY2022Jun 30, 2022-$6.26M-452.9%
Q1 FY2022Mar 31, 2022$8.49M+696.2%
Q4 FY2021Dec 31, 2021$7.61M+703.3%
Q1 FY2021Mar 31, 2021$6.76M–
Q4 FY2020Dec 31, 2020$1.77M+3915.2%
Q3 FY2020Sep 30, 2020$1.07M–
Q2 FY2020Jun 30, 2020$946.96K–
Q1 FY2020Mar 31, 2020-$407.11K–
Q4 FY2019Dec 31, 2019$44.18K–
Q3 FY2019Sep 30, 2019-$2.13M–
Q2 FY2019Jun 30, 2019-$15.83M-1592.5%
Q1 FY2019Mar 31, 2019-$6.22M–
Q4 FY2018Dec 31, 2018-$1.37M–
Q3 FY2018Sep 30, 2018-$1.73M-166.8%
Q2 FY2018Jun 30, 2018$1.06M–
Q1 FY2018Mar 31, 2018-$871.84K-749.1%
Q4 FY2017Dec 31, 2017-$864.99K-1182.2%
Q3 FY2017Sep 30, 2017$2.59M–
Q2 FY2017Jun 30, 2017-$92.07K–
Q1 FY2017Mar 31, 2017$134.32K–
Q4 FY2016Dec 31, 2016$79.93K–
Q3 FY2016Sep 30, 2016-$306.37K–

More MariMed figures

See a number that looks wrong?